drugset
drugset / Trial / NCT05285696

Study to Evaluate the Safety and Dosimetry of [68Ga]-NOTA-hGZP (CSB-111) PET Imaging in Healthy Human Volunteers.

NCT05285696 ↗

Phase 1 Completed 6 enrolled Cytosite Biopharma Inc. University of Alabama at Birmingham · collab
NaSingle-groupOpen-labelDiagnostic

Summary

Phase one study to evaluate the safety and dosimetry of \[68Ga\]-NOTA-hGZP (CSB-111) PET Imaging in healthy human volunteers.

Timeline

Start
2022-09-01
Primary completion
2023-04-01
Completion
2023-05-20

Drugs

EvaluationDrugModalityDoseRoute
Subject CSB-111 Unknown 40 ug Intravenous

Indications

No indication recorded.